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SUMMARY – Lead endocarditis is an infrequent but potentially lethal complication of im-
plantable cardioverter defibrillator (ICD) implantation. We report a case of a 53-year-old man with 
ICD who was admitted to our hospital because of fever, chills, shivering, headache and malaise. Tr-
ansthoracic echocardiography detected a structure highly suspect of vegetation located on the ICD 
lead. Transesophageal echocardiography showed a 20x12 mm mobile vegetation attached to the 
ICD lead in the right atrium. The infection was caused by methicillin-resistant Staphylococcus epi-
dermidis (MRSE), which was isolated from blood cultures. Treatment consisted of surgical removal 
of the ICD lead and placement of new epicardial ICD leads. Three years afterwards, the patient 
remained asymptomatic. To our knowledge, this is the first such case reported from Croatia.
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Introduction
Lead endocarditis occurs in less than 1% of per-
manent pacemaker (PM) and implantable cardiovert-
er defibrillator (ICD) implants. ICD endocarditis may 
consist of pocket infections, lead infections, lead infec-
tions complicated by valve endocarditis, or a combina-
tion of these1. It is a potentially lethal complication 
and mortality rates of 30% to 35% have been reported. 
Transthoracic echocardiography (TTE) may identify 
lead vegetation, but it has not been established as a 
major diagnostic criterion for ICD lead endocarditis 
due to its low sensitivity. Transesophageal echocar-
diography (TEE) allows for exploration of the entire 
pacing system from the superior vena cava to the right 
ventricle2. TEE is a useful diagnostic technique for 
detection and characterization of lead infection.
We describe a case of recurrent staphylococcal 
bacteremia due to ICD lead endocarditis.
Case Report
A 53-year-old man was admitted to Dr Fran 
Mihaljević University Hospital for Infectious Dis-
eases with high fever of up to 40.5 °C lasting for three 
days, accompanied by chills, shivering, headache and 
malaise. Later, it was revealed that he had experienced 
similar episodes of fever, shivering and malaise, recur-
ring daily for half an hour on average over the last 
four months, for which he did not seek medical as-
sistance.
His past medical history was significant for prior 
implantation of three bare metal stents (BMS) in the 
left descending artery, left circumflex coronary artery 
and right coronary artery due to angina pectoris four 
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years before, which was followed by implantation of 
another three BMS because of in-stent restenosis a 
year later. Finally, one more year later an ICD was 
implanted for recurrent sustained ventricular tachy-
cardia. 
On admission, the patient was febrile with body 
temperature of 38.8 °C, hypotensive (blood pressure 
80/55 mm Hg), diaphoretic and exhausted. Physical 
examination revealed no abnormalities. Electrocar-
diogram (ECG) recorded sinus rhythm with a heart 
rate of 110 bpm with single premature ventricular 
beats and nonspecific T-wave changes. Chest x-ray 
was normal. TTE detected a structure highly suspect 
of vegetation located on an ICD lead, followed by 
TEE that showed 20x12 mm mobile vegetation at-
tached to the ICD lead in the right atrium (Fig. 1).
Laboratory test results revealed elevated erythro-
cyte sedimentation rate (84 mm/h), while leukocyte 
count was 8.6x109/L, erythrocyte count 4.5x1012/L, 
hemoglobin 119 g/L, CRP 185.2 mg/L, bilirubin 32.5 
µmol/L and γ-GT 138 mmol/L. Urine was normal 
on routine and microscopic examination and urine 
cultures remained sterile. Therapy with intravenous 
amoxicillin and potassium clavulanate was initiated, 
and after the collection of blood cultures, it was ex-
changed for a combination of rifampicin, gentamicin 
and vancomycin. Since methicillin-resistant Staphylo-
coccus epidermidis (MRSE) isolated from blood culture 
was proven sensitive to vancomycin, the other two an-
tibiotics were discontinued after a week.
Under antibiotic treatment, the patient gradually 
became subfebrile and then afebrile in the last two 
days. Since urgent surgical treatment was indicated, 
he was transferred to Cardiac Surgery after altogether 
18 days of antibiotic treatment. On the second day of 
transfer, the patient underwent surgical ICD lead ex-
Fig. 1. Transesophageal echocardiogram showing large vegetation attached to the implantable cardioverter defibrillator lead 
in the right atrium (arrow); RA, right atrium; LA, left atrium.
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traction (Fig. 2). It was followed by valvuloplasty of 
tricuspid valve with ring implantation (Edwards Life-
sciences Anuloplasty Ring 32 mm) due to valve endo-
carditis and epicardial reimplantation of ICD leads. 
Microbiological analysis of the extracted lead identi-
fied MRSE as the causative organism of endocarditis. 
Echocardiographic survey after the procedure showed 
normal function of the left ventricle and heart valves. 
Vancomycin therapy was continued for 14 days post-
explantation. Postoperative period was uneventful and 
36 months later the patient remained asymptomatic. 
To our knowledge, this is the first case of implantable 
cardioverter defibrillator lead endocarditis reported 
from Croatia.
Discussion
Lead endocarditis after pacemaker and ICD im-
plantation is a rare but potentially lethal complication. 
It is therefore necessary to complete diagnostic work-
up as fast as possible, isolate the pathogenic agent and 
apply appropriate antimicrobial therapy followed by 
removal of the infected material. 
Lead endocarditis can appear at different points in 
time after the implantation. Early-onset endocarditis 
is defined as endocarditis occurring within 12 months 
after implantation, and late-onset endocarditis is de-
fined as endocarditis after 12 months of implantation3. 
The mean time interval between the implantation of 
a permanent PM or ICD and the first appearance of 
symptoms of endocarditis is 2.9 years. Lead endo-
carditis may occur in the early or late postoperative 
period, but only a small number of patients (16.9%) 
present with an early infection within less than two 
months of the implantation3. In our patient, this in-
terval was 2 years. 
Whenever ICD or permanent PM lead endocardi-
tis is suspected, TEE is the diagnostic modality of 
choice for detection of vegetations4. The sensitivity of 
TTE is significantly lower (23%-30%) compared with 
TEE (91%-96%) in the diagnosis of permanent PM 
and ICD lead endocarditis3,5.
Like the endocarditis of heart valves, the endo-
carditis of PM and ICD leads is also diagnosed by 
the use of Duke criteria; hence, positive blood cul-
tures and vegetation noted on the lead will confirm 
the diagnosis3,6. Our patient was febrile, had a positive 
blood culture with isolated causative organism from 
MRSE group and vegetations were found on the lead 
and on the tricuspid valve. 
It took three days from the onset of fever that led 
to hospitalization to the definite diagnosis. The fact 
that the patient had had recurrent episodes of fever 
for 4 months before admission (during which he had 
never sought medical assistance), suggested recurrent 
bacteremia. Finally, the lead vegetation culture was 
positive and the pathogenic agent was identified by 
microbiological analysis.
Antibiotic therapy is mandatory before and after 
lead extraction, and its intravenous administration 
for 4 weeks is considered to be sufficient. Patients 
who do not undergo lead extraction are required 
to receive prolonged antibiotic therapy for 6 weeks. 
The majority of patients are subjected to lead extrac-
tion, whether percutaneous or surgical. The way of 
lead extraction is determined by the size and mobility 
of the vegetation as well as by possible valve endo-
carditis. For smaller (<10 mm) and less mobile vegeta-
tions, the method of choice is percutaneous extrac-
tion, while larger and more mobile vegetations along 
with concomitant valve endocarditis are an indication 
for surgical intervention. After surgical removal, re-
implantation of a permanent PM or an ICD is accom-
plished by the placement of epicardial leads, while af-
ter percutaneous extraction it is done by transvenous 
approach of lead placing. In our case, a very large and 
mobile vegetation together with accompanying valve 
endocarditis mandated surgical approach and use of 
epicardial leads. The overall time interval from the di-
agnosis to surgical treatment was 19 days.
The treatment of PM and ICD lead endocarditis 
is based on the combination of antibiotic therapy and 
surgical intervention. Literature data indicate that 
best results are achieved by antibiotic therapy before 
and after lead removal. If percutaneous or surgical ex-
Fig. 2. Vegetation attached to the implantable cardioverter 
defibrillator lead recorded immediately after surgery.
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Sažetak
EHOKARDIOGRAFIJA U OTKRIVANJU ENDOKARDITISA IZAZVANOG UGRADNJOM ELEKTRODE 
IMPLANTABILNOG KARDIOVERTER DEFIBRILATORA: PRIKAZ SLUČAJA
J. Vincelj, B. Baršić, I. Rudež, D. Unić i M. Udovičić
Endokarditis elektrode je rijetka no potencijalno smrtonosna komplikacija ugradnje implantabilnog kardioverter de-
fibrilatora (ICD). Prikazujemo slučaj 53 godine starog muškarca s implantiranim ICD-om koji je hospitaliziran zbog 
febriliteta, groznice, tresavice i općeg lošeg stanja. Transtorakalnim ultrazvukom srca je otkrivena tvorba vrlo sumnjiva na 
vegetaciju na elektrodi ICD-a, da bi transezofagusnim ultrazvukom bila prikazana vegetacija veličine 20x12 mm pričvr-
šćena za elektrodu ICD-a u desnom atriju. Uzročnik endokarditisa je bio meticilin rezistentni Staphylococcus epidermidis 
(MRSE) koji je izoliran u hemokulturi. Liječenje se sastojalo od kirurškog odstranjenja elektrode ICD-a i njene zamjene 
novim, epikardijalnim elektrodama. Tri godine kasnije bolesnik je i dalje bez tegoba. Prema našim saznanjima, ovo je prvi 
ovakav slučaj dosad opisan u Hrvatskoj.
Ključne riječi: Defibrilatori, ugradbeni – štetni učinci; Endokarditis; Infekcije kod ugradnje proteze; Infekcije uzrokovane 
bakterijom MRSE; Ehokardiografija
traction is not performed, then prolonged antibiotic 
therapy is required, although with worse outcome and 
higher mortality rates2,7.
There are two possible origins of PM and ICD lead 
endocarditis. The first one is bacteremia, which can 
cause colonization of the lead by pathogen agents, and 
the second one is local infection of the area around 
generator and its distal progression along the lead4,7. 
Thorough inspection of the generator implantation 
area is mandatory for early prevention, timely detec-
tion and possible treatment of a potential lead infec-
tion. Since no infection of the generator implantation 
area was detected in our patient, we assumed bacter-
emia to be the source of infection.
In conclusion, the application of TTE and TEE 
in patients with suspected ICD lead endocarditis en-
ables making an accurate and early diagnosis, which 
is essential for timely therapy initiation and better 
outcome. ICD lead endocarditis can be safely man-
aged by surgical lead extraction with reimplantation 
of epicardial patch leads after intravenous antibiotic 
therapy.
References
1. COREY GR, LALANI T. Risk of intravascular cardiac de-
vice infections in patients with bacteraemia: impact on device 
removal. Int J Antimicrob Agents 2008;325:526-9.
2. del RIO A, ANGUERA I, MIRO JM, et al. Surgical treat-
ment of pacemaker and defibrillator lead endocarditis. Chest 
2003;124:1451-9. 
3. KERUT EK, HANAWALT C, EVERSON CT. Role of 
echocardiography laboratory in diagnosis and management 
of pacemaker and implantable cardiac defibrillator infection. 
Echocardiography 2007;24:1008-12.
4. WASSON S, AGGARWAL K, FLAKER G, REDDY HK. 
Role of transesophageal echocardiography in detecting im-
plantable cardioverter defibrillator lead infection. Echocar-
diography 2003;20:289-90.
5. DUMONT E, CAMUS C, VICTOR F, et al. Suspected 
pacemaker or defibrillator transvenous lead infection: pro-
spective assessment of a TEE-guided therapeutic strategy. 
Eur Heart J 2003;24:1779-87.
6. HABIB G. Management of infective endocarditis. Heart 
2006;92:124-30. 
7. BADDOUR LM, BETTMANN MA, BOLGER AF, et al. 
Nonvalvular cardiovascular device-related infections. Circu-
lation 2003;108:2015-31.
